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The aim of the present study was to examine the factor structure and psychometric prop-
erties of the short version of the Children’s Somatization Inventory (CSI-24) in Poland. The
CSI-24 is a self-report questionnaire designed to assess somatic symptoms in children and
adolescents. A total of 733 children and adolescents, aged 12–17 years, participated in this
research. The participants for this study were recruited from urban and suburban schools
of Opole province in South Western Poland. In addition to the CSI-24, all participants com-
pleted the Spence Children’s Anxiety Scale (SCAS) and the Strength and Difficulties Ques-
tionnaire (SDQ). The correlated four-factor model that included four-correlated dimensions
(pain/weakness, gastrointestinal problems, cardiovascular symptoms, and pseudoneuro-
logical problems) showed a better fit compared to the single-factor model. The Cronbach’s
Alpha for the CSI-24 was 0.91. Somatic symptoms correlated significantly highly with the
SCAS total scores and the SDQ emotional subscale, suggesting good construct validity.
Somatic symptoms had low correlation with the SDQ behavioral problems symptoms, sug-
gesting adequate discriminant validity.The CSI-24 reliably measured somatic symptoms in
children and adolescents in Poland.
Keywords: Children’s Somatization Inventory, anxiety disorders, somatic symptoms, Poland, children and
adolescents
INTRODUCTION
Somatic symptoms such as stomach aches and headaches occur
frequently in children and adolescents in the general population (1,
2). Somatic symptoms are more prevalent in girls than in boys, and
they tend to increase with age (3). Youths with somatic symptoms
tend to experience impairment in academic and social functioning
including a high level of absenteeism, poor academic achievement,
and psychosocial difficulties (4). Furthermore, somatic symptoms
are linked to an increase in health care services utilization, thus,
they tend to exert a heavy financial burden on both the families
and the health care system (4).
Somatic symptoms co-occur frequently with anxiety and
depression (5) and that they tend to be stable over time (6).
Chronic somatic symptoms in childhood significantly predicts
psychopathology in adulthood (7).These observations highlight
the importance of understanding and screening somatic symp-
toms in children and adolescents.
The Children’s Somatization Inventory [CSI; (8)] is a self-
report questionnaire for assessing somatic symptoms in children
and adolescents. Its original version consists of 35 items (referred
to as CSI-35) from which items were taken from the symptoms of
somatization disorder (9), the somatization factor of the Hopkins
Symptom Checklist (10), and common symptoms of functional
gastrointestinal (GI) disorder (i.e., constipation). Children and
adolescents report the extent to which they experience each symp-
tom in the past 2 weeks on a 5-point scale ranging from “not at
all” (0) to “a whole lot” (4). Somatization can be defined as a
psychological distress that is manifested in the form of somatic
symptoms.
Studies that examined the factor structure of the CSI-35 have
reported considerable inconsistency regarding the factor structure
of this instrument. For example, studies conducted in the US (11)
and in the Ukraine (12) reported a four-factor structure on the
CSI: pseudoneurological, cardiovascular, GI, and pain/weakness
symptoms. However, in a study in the Netherlands (13) and the
UK (3), only three factors were found: pain/weakness, GI, and
pseudoneurological. In all of these studies, some of the CSI items
are rarely endorsed and the item-total correlations were low. This
is not surprising because some of the items were taken from the
symptoms criteria for somatization disorders in adults which may
not be applicable to children (14).
In a recent study by Walker and colleagues (14) that examined
the dimensionality of the CSI-35, 11 statistically weak items (lump
in throat, deafness, double vision, blindness, fainting/passing
out, memory loss/amnesia, seizures, convulsion, trouble walking,
paralysis/muscle weakness, difficulty urinating, pain-urinating)
were deleted, leaving 24 items (referred to as CSI-24). The authors
conducted a principal component analysis and found a single
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large component which explained almost 30% of the total vari-
ance and containing symptoms of various organs; a second factor
containing symptoms related to GI symptoms was also found, but
it was regarded as weak. The authors also conducted a confirma-
tory factor analysis (CFA) and found that the CSI-24 did not fit a
single-factor model. Because of its better psychometric properties,
shorter time completion and containing more appropriate items
for children and adolescents, the authors suggested that the CSI-24
is preferable to the CSI-35.
In view of the above findings, it remains unclear whether a
general somatization factor exists or whether somatic symptoms
would be better represented by multidimensionality. Therefore,
the main aim of this study was to test the factor structure of the
Polish translation of the CSI-24: one-factor model (14), three-
factor model (3, 13), four-factor model (11, 12), and two models
including a general factor and specific group factors (i.e., bifac-
tor models). A bifactor model would include a general factor that
accounts for relationships between items, but also specific factors
that account for the unique variance among the items above and
beyond the general factor (15). Other aims of this study were to
examine the relationship of somatic symptoms with other psy-
chopathology, and to examine gender and age patterns of somatic
symptoms.
MATERIALS AND METHODS
PARTICIPANTS
The participants for this study were recruited from five urban
and suburban schools of the Opole province in South Western
Poland. A total of 733 adolescents participated in the study and
of these 51.1% were girls. They ranged in age from 12 to 17 years
(mean= 15.4, SD= 1.59). About 89.5% of the participants indi-
cated Christianity as their religion.
Consent from the parent was obtained before the youths could
participate in the study. Each participating school was sent a let-
ter that described the aim of the present study and the procedure
involved. The youths were informed about the aim of the study
as well as about the voluntary nature and anonymity of their
participation in this study. The questionnaires were completed
by the participants in groups in the designated classrooms. A
research assistant was available to provide answers if necessary
and to ensure independent responding. Approval to conduct this
study was obtained from the Psychology Ethic Committee at the
University of Roehampton.
MEASURES
In addition to the CSI-24, the participants also completed a brief
questionnaire to obtain demographic characteristics, the Strengths
and Difficulties Questionnaire (SDQ) (16), and the Spence Chil-
dren’s Anxiety Scale (SCAS) (17). The English version of these
questionnaires was adapted and translated to Polish according to
guidelines that are widely accepted for the successful translation
of instruments in cross-cultural research (18).
The Strengths and Difficulties Questionnaire (16) was used to
assess general difficulties and positive attributes. Its 25 items
are divided into 5 scales, which generate scores for conduct
problems, hyperactivity-inattention, emotional symptoms, peer
problems, and pro-social behavior; the “emotional symptoms”
subscale assesses anxiety and depressive symptoms. Each of the
items is rated on a 3-point scale, ranging from “not true” (0) to
“certainly true” (2). In the present study, the Cronbach’s Alpha for
the total SDQ scores was 0.79.
The Spence Children’s Anxiety Scale (17) is a 38-item mea-
sure of anxiety symptoms in children and adolescents. The items
reflect symptoms of the main DSM-IV anxiety disorders, including
separation anxiety, social phobia, obsessive-compulsive disorder
(OCD), panic/agoraphobia, physical injury fears, and generalized
anxiety disorder (GAD). Each item is rated on a 4-point scale in
terms of its frequency from “never” (0) to “always” (3). In the
present study, the Cronbach’s Alpha for the SCAS was 0.93.
STATISTICAL ANALYSIS
The Statistical Package for Social Science (SPSS) version 19.0
and the Structural Equation Modeling package EQS version 6.1
were used to perform the statistical analyses. The CSI-24 data
were 99.2% complete, with 96% of cases having no missing
items. With less than the 5% of cases having any missing data,
any reasonable method of dealing with missing values could be
used (19). Missing values were replaced using expectation maxi-
mization (EM) algorithm (20) to fulfill the 4% of missing items
based on non-missing responses (21). This imputation method
is thought to be better than the mean imputation since it pre-
serves the variance. The average item mean and standard devia-
tion were the same both before and after imputation (M = 0.62,
SD= 0.93).
Corrected item-total correlations were calculated to examine
how each item contributed to the overall scale. The Cronbach’s
alpha was calculated to determine the internal consistency of the
CSI-24.
Confirmatory factor analysis was performed to compare the
one, three, and four-factor structure of the CSI (Figures 1A–C).
The last two factors were considered to be factor-correlated. The
Lagrange Multiplier tests (LM test) were also conducted to deter-
mine unspecified parameters in the model. Statistically significant
LM Chi-square values would argue for the presence of factor cross-
loadings and error covariances (22). Two bifactor models were
specified in which each item loaded onto a general somatization
factor, and items also loaded onto one of the three or the four
domain-specific factors (Figures 1D,E).
Since the observed variables included in the model were ordinal
and presented a certain level of skewness, a maximum likelihood
robust method based on polychoric correlations was used (23).
Satorra–Bentler scaled Chi-square, the Normed Fit Index (NFI),
the Non-Normed Fit Index (NNFI), the Comparative Fit Index
(CFI), the Root Mean Square Error of Approximation (RMSEA),
the Standardized Root Mean Square Residual (SRMR) were used
as goodness-of-fit indices. Values of NFI, NNFI, and CFI higher
than 0.90 indicate adequate fit (24). RMSEA of 0.05 or lower is
indicative of an adequate fit (25); a favorable value of the SRMR
is less than 0.10 (26). Robust versions of all fit statistics were com-
puted except for the SRMR, which has no robust counterpart but
summarizes the fit in a way the other (robust) indices do not. The
Akaike’s Information Criterion (AIC), the consistent AIC (CAIC),
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FIGURE 1 | Five factor models tested with CFA. (A) unidimensional model
(14). (B) three-correlated factor model (3, 13). Item 16 (“heart beating”) was
considered as part of the pseudoneurological symptoms (3). (C) four-
correlated factor model (11, 12). Item 1 (“headaches”) was not included as
was proposed by the authors. (D) bifactor model with one general factor
(somatization) and three specific factors (pain/weakness, gastrointestinal
problems, and pseudoneurological problems). (E) bifactor model with one
general factor (somatization) and four factors (Pain/weakness, cardiovascular
problems, gastrointestinal problems, and pseudoneurological problems). This
model included item 1 (“headaches”) as being part of the general factor.
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and the Expected Cross-Validation Index (ECVI) were used as
parsimony indices: smaller model AIC, CAIC, and ECVI than the
comparison model indicate better fit.
Non-parametric correlation tests (Spearman rank) were com-
puted between the CSI and the SCAS and the SDQ to assess the
convergent and divergent validity of the CSI. Gender and age
effects were examined with Mann–Whitney and Kruskal–Wallis
tests.
RESULTS
Descriptive analyses of the CSI-24 items (Table 1) showed the
lowest mean for items “difficulty swallowing,” “losing voice,” and
“vomiting.” The highest mean was obtained for “headaches,” fol-
lowed by “low energy,” “pain in stomach or abdomen.” There was
a marked skewness or kurtosis for the following items: “consti-
pation,” “loose BM’s or diarrhea,” “difficulty swallowing,” “losing
voice,” “vomiting,” and “food making sick.” All items obtained a
Table 1 | Characteristics of all the CSI-24 items.
CSI-24 Symptoms endorsed
at any level
of severity (%)
Symptoms endorsed
as 3 (a lot) or
4 (a whole lot) (%)
Mean SD Skewness Kurtosis r tot
1. Headaches 70.4 12.1 1.32 1.09 0.36 −0.58 0.50
2. Faintless or dizziness 41.1 6.2 0.70 1.00 1.38 1.24 0.62
3. Pain heart or chest 38.2 7.3 0.68 1.03 1.53 1.63 0.55
4. Low energy 63.1 11.6 1.13 1.13 0.85 0.02 0.54
5. Pains lower back 43.8 13.2 0.89 1.19 1.12 0.07 0.48
6. Sore muscles 57.7 9.1 1.01 1.09 0.93 0.21 0.50
7. Trouble breath 26.0 4.7 0.46 0.90 2.24 4.72 0.61
8. Hot or cold spells 38.2 9.1 0.72 1.10 1.52 1.41 0.60
9. Numbness or tingling 48.6 10.4 0.87 1.10 1.14 0.40 0.59
10. Weakness 34.4 4.7 0.54 0.89 1.80 2.92 0.62
11. Heavy feelings arms or legs 27.0 2.3 0.39 0.76 2.36 6.23 0.56
12. Nausea or upset stomach 40.6 7.6 0.71 1.05 1.49 1.50 0.64
13. Constipation 17.2 2.6 0.27 0.68 3.10 10.35 0.48
14. Loose BM’s or diarrhea 16.9 2.6 0.27 0.73 3.39 12.49 0.43
15. Pain stomach or abdomen 62.3 10.7 1.06 1.06 0.82 −0.04 0.53
16. Heart beating fast 27.3 5.4 0.48 0.92 2.20 4.44 0.57
17. Difficulty swallowing 12.8 2.3 0.22 0.67 3.57 13.57 0.53
18. Losing voice 13.9 1.6 0.22 0.62 3.58 14.57 0.41
19. Blurred vision 23.9 3.3 0.39 0.81 2.45 6.19 0.44
20. Vomiting 12.8 1.6 0.22 0.65 3.37 12.11 0.40
21. Floated or gassy 36.3 8.0 0.67 1.07 1.69 2.10 0.35
22. Food making sick 21.1 2.5 0.33 0.75 2.77 8.36 0.61
23. Pains knees, elbows, or joints 41.6 9.1 0.77 1.09 1.34 0.91 0.46
24. Pain arms or legs 38.4 6.2 0.64 1.00 1.72 2.51 0.58
r tot, Corrected item-total correlation; the standard error of skewness was 0.09 and 0.18 for kurtosis.
Table 2 | Goodness-of-fit indices for the one-, three-, four-factors, and bifactor models of the CSI-24.
Fit indices 1 Factor 3 Factor 4 Factor Bifactor model
(3 subfactors)
Bifactor model
(4 subfactors)
Satorra–Bentler Chi-squared (df) 811.08 (247) 759.02 504.52 (218) 568.86 (221) 662.46 (229)
NFI 0.965 0.968 0.977 0.976 0.972
NNFI 0.973 0.975 0.985 0.981 0.977
CFI 0.976 0.978 0.987 0.985 0.981
RMSEA (95% CI) 0.056 (0.052–0.060) 0.054 (0.049–0.058) 0.042 (0.038–0.047) 0.046 (0.042–0.051) 0.051 (0.046–0.055)
SRMR 0.060 0.059 0.052 0.50 0.055
Model AIC 317.08 269.02 68.52 126.87 204.46
Model CAIC −1065.42 −1102.28 −1151.661 −1110.10 −1077.28
ECVI 3.22 3.09 2.18 2.52 2.78
df, degrees of freedom; CI, confidential interval.
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corrected item-total correlation greater than the rule of thumb
minimum value of 0.20 (27).
CONFIRMATORY FACTOR ANALYSES
Lagrange multiplier test in the one-factor model showed that the
highest LM Test incremental multivariate Chi-square values rep-
resent error covariances between items 13 (“constipation”) and
14 (“Loose BM’s or diarrhea”), items 14 (“diarrhea”) and 22
(“Food intolerance”), items 13 (“constipation”) and 21 (“floated
or gassy”), items 14 (“diarrhea”) and 21 (“floated or gassy”), and
between item 23 (“pain joints”) and item 24 (“pain in arms and
legs”). To understand these results, it is important to look at the
content of these items. It seems that there might be an overlap
between them (i.e., pain in joints and pain in arms or legs), and
in other cases, items refer to symptoms that occur generally at
the same time (i.e., constipation and being gassy). Therefore, the
one-factor model was re-specified including these parameters.
For the three-factor model, the LM-test showed the fol-
lowing misspecified parameters (error covariances): items 13
(“constipation”) and 14 (“diarrhea”), items 14 (“diarrhea”) and
21 (“floated or gassy”), items 13 (“constipation”) and 21 (“floated
or gassy”), and items 23 (“pain joints”) and 24 (“pain in arms
and legs”). The LM-test in the four-factor model included as mis-
specified parameters the following error covariances: 23 (“Pain in
knees, elbows, or joints”) and 24 (“Pain in arms and legs”), items
13 (“constipation”) and 14 (“Loose BM’s or diarrhea”), items 14
(“diarrhea”) and 21 (“floated or gassy”), and items 13 (“constipa-
tion”) and 21 (“floated or gassy”). Moreover, the LM-test showed
as misspecified a cross-loading from factor 4 (pseudoneurologi-
cal) to item 17 (“difficulty swallowing”), and from factor 2 (GI
problems) to item 22 (“Food intolerance”). After reviewing the
content of each item, it was considered that these error covariances
and cross-loadings should be kept in both the three- and four-
factor models including these new parameters. The goodness-
of-fit indices of the new re-specified models were better than
the models without these items, and the different values of the
Satorra–Bentler Chi-Squared [calculated with the computation
process from (28)] were also significant (p< 0.001).
Table 3 | Factor-loadings and inter-factor correlations for the CSI-24.
One-F Three-F model Four-F model Bifactor Model (3 subfactors) Bifactor model (4 subfactors)
F1 F1 F2 F3 F1 F2 F3 F4 g F1 F2 F3 g F1 F2 F3 F4
CSI1 0.56* 0.57* 0.57* −0.11 0.55*
CSI2 0.71* 0.70* 0.72* 0.74* −0.19* 0.68* 0.29*
CSI3 0.66* 0.67* 0.69* 0.69* −0.03 0.61* 0.51*
CSI4 0.62* 0.60* 0.63* 0.60* −0.07 0.62* 0.04
CSI5 0.56* 0.57* 0.57* 0.50* 0.26* 0.56* 0.04
CSI6 0.54* 0.55* 0.55* 0.44* 0.40 0.54* 0.02
CSI7 0.75* 0.75* 0.78* 0.75* 0.02 0.72* 0.31*
CSI8 0.71* 0.70* 0.74* 0.72* 0.003 0.69* 0.26*
CSI9 0.67* 0.68* 0.68* 0.63* 0.18* 0.67* 0.08
CSI10 0.74* 0.74* 0.76 0.70* 0.16* 0.74* 0.04
CSI11 0.69* 0.70* 0.74 0.59* 0.34* 0.69* 0.17*
CSI12 0.75* 0.82* 0.82* 0.79* 0.28* 0.76* 0.05
CSI13 0.62* 0.62* 0.60* 0.61* 0.08 0.62* 0.40*
CSI14 0.57* 0.61* 0.64* 0.60* 0.40* 0.57* 0.75*
CSI15 0.61* 0.65* 0.65* 0.63* 0.19* 0.61* 0.03
CSI16 0.72* 0.71* 0.73* 0.73* 0.005 0.69* 0.25*
CSI17 0.78* 0.79* 0.17 0.71* 0.75* 0.08 0.78* 0.01
CSI18 0.60* 0.61* 0.71* 0.58* 0.45* 0.60* 0.57*
CSI19 0.60* 0.60* 0.67* 0.60* 0.29* 0.59* 0.23*
CSI20 0.60* 0.66* 0.70* 0.66* 0.59* 0.62* 0.25*
CSI21 0.45* 0.45* 0.47* 0.45* 0.24* 0.45* 0.45*
CSI22 0.76* 0.80* 0.69* 0.15 0.79* 0.31* 0.78* −0.01
CSI23 0.51* 0.53* 0.54* 0.39* 0.47* 0.51* 0.47*
CSI24 0.63* 0.65* 0.68* 0.49* 0.55* 0.62* 0.93*
INTER-FACTOR CORRELATIONS
F1 1.00 0.90 1.00 1.00 0.83 0.91 0.79
F2 1.00 0.94 1.00 0.80 0.78
F3 1.00 1.00 0.83
F4 1.00
g, general factor; *Test statistics significant at the 5% level.
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Table 2 includes the goodness-of-fit indices with these new
parameters in the three models. Overall, the goodness-of-fit
indices were good in all models under test. However, the model
which yielded better fit indices as well as better parsimonious
indices was the four-factor model. Bifactor model including
the three domain-specific factors (i.e., GI, pseudoneurological,
and pain/weakness) showed better indices than the three-factor
model, whereas goodness-of-fit of the bifactor model with the
four domain-specific factors was in general poorer than the
four-correlated factors.
Factors loadings in the one-factor model ranged from 0.45
(item 21) to 0.78 (item 17) (Table 3). In the three-factor and
four-factor models, items showed high loadings on their respec-
tive hypothesized factors. In the four-factor model, however, items
17 (“difficulty swallowing”) and 22 (“food intolerance”) had low
values in their cross-factor loading (0.17 and 0.15, respectively),
which were marginally significant. Factor loadings to the general
factor in the bifactor models tend to go down slightly compared
with the loadings in the one-factor solution. This might occur
because the factor in the unidimensional model is likely a con-
glomeration of the common variance present through all items due
to shared content (29). In the bifactor model with three specific
group factors, 15 out of 24 items had significant factor loadings
on the general factor as well as on the specific factors. Particu-
lar symptoms did not share symptom specific variances and only
loaded significantly on the general factor (e.g.,“trouble breathing”
and“heart beating fast”). Similarly, in the bifactor model with four
specific group factors, 14 out of 24 items showed significant factor
loadings on both the general factor and the specific group factor.
Again, some items did not significantly load onto the specific factor
(e.g.,“sore muscles” or“difficulty swallowing”). Inter-factor corre-
lations were very high, both in the three-factor and the four-factor
model.
INTERNAL CONSISTENCY AND VALIDITY
The Cronbach’s alpha of the CSI-24 was 0.91. Internal consis-
tency of the four-factor model was good in three of its subscales.
Cronbach’s alpha coefficient of the GI factor was 0.72, for the
cardiovascular problems was 0.84, and for the pain/weakness was
0.76. The internal consistency of the pseudoneurological factor
was poor, with a Cronbach’s alpha of 0.48.
The CSI-24 total scores correlated highly with the SCAS total
scores and all its subscales, as well as with the SDQ total scores
and all its subscales except for the pro-social behavior subscale
(Table 4). Correlations between the CSI-24 and the SDQ conduct
problems and ADHD subscales were high (both equal to 0.40).
In order to determine whether correlations between the CSI-24
and the SCAS and the SDQ emotional problems were signifi-
cantly stronger (convergent validity) than correlations between
the CSI-24 and the SDQ conduct problems and ADHD subscales
(divergent validity), we used the Steiger’s Z test (30), following
the recommendation of Meng et al. (31) for correlated correla-
tions. Results showed that the relationship between the CSI-24
and the SCAS OCD, panic, GAD, SCAS total score, and SDQ
emotional problems were significantly greater than the correla-
tions between the CSI-24 and the SDQ conduct problems and
the correlations between the CSI-24 and the SDQ hyperactivity
Table 4 | Correlations between CSI-24 and other psychopathological
measures.
CSI-24 total score
SPENCE CHILDREN’S ANXIETY SCALE
Separation anxiety 0.39**
Social phobia 0.39**
Obsessive compulsive 0.49**
Panic disorder 0.59**
Physical injuries fears 0.36**
Generalized anxiety 0.48**
Total scores 0.56**
STRENGTH AND DIFFICULTIES QUESTIONNAIRE
Emotional symptoms 0.59**
Conduct problems 0.40**
Hyperactivity-inattention 0.40**
Peer problems 0.24**
Pro-social behavior 0.03
Total scores 0.59**
**Significant at the 0.01 level (two-tailed).
(z > 1.96, p< 0.05). However, results showed that correlations
between the CSI-24 and the SAD, Social phobia, and fears sub-
scales were not significantly different from correlations between
the CSI-24 and both the SDQ conduct problems and hyperactivity
subscales (z < 1.96, p> 0.5).
GENDER AND AGE EFFECTS
The mean of the CSI-24 total score on the whole
sample was 14.95 (SD= 12.99). We also calculated the
means and standard errors of the four factors: GI fac-
tor (mean= 3.21, SD= 3.47); cardiovascular (mean= 7.14,
SD= 6.60), pain/weakness (mean= 2.67, SD= 3.24), and
pseudoneurological factor (mean= 0.60, SD= 1.16). Girls had
significantly higher mean scores than boys on the CSI-24 total
score, GI, cardiovascular, and pseudoneurological symptoms
(Table 5). Comparisons between three groups (12–13, 14–15, 16–
17 years) in terms of the mean scores on the CSI-24 and the four
subscales yielded no significant differences.
Due to the violation of the normality assumption,
Age×Gender interaction was not examined. However, we
examined the mean scores of the CSI-24 among boys and girls
separately within the three age groups. There were no signifi-
cant differences in the different CSI scores between age groups
according to the participants’ gender (Table 5).
DISCUSSION
The main purpose of this article was to examine the factor struc-
ture, reliability, and the validity of the Polish version of the
CIS-24. Another aim was to examine the effects of gender and
age on the frequency of somatic symptoms. Our main findings
are summarized as follows: first, the better fit of the correlated
four-factor model compared to the single-factor model supports
the multicomponential nature of the CSI-24 with four-correlated
dimensions: pain/weakness, GI problems, cardiovascular symp-
toms, and pseudoneurological problems. This factor structure
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corresponded to the factor structure reported by Garber et al. (11)
and Litcher et al. (12) when the original CIS-35 was used with chil-
dren and adolescents in the US and Ukraine. However, our findings
were inconsistent with those by Walker et al. (14) in which one
dominant general factor was found when a PCA was conducted.
However, the bifactor models under test yielded good fit indices
and the inspection of the factor loadings showed that many symp-
toms significantly loaded onto both the general factor and the
specific factors. This would suggest that the variability of a CSI-24
symptom is determined by two sources of systematic variance, one
from a general somatization factor and the other from a specific
factor. Some authors have suggested that this could be explained
in the light of the presence of an affective component associated
to the symptom experience as the general factor, whereas the spe-
cific factors would correspond to the sensory part of the symptom
experience (32). Another point of concern is the high inter-factor
correlations between the three and the four factors, which could
be suggestive of the presence of a second-order factor. In such
a model, correlations between factors would be accounted for by
the general somatization factor. The authors conducted a CFA with
second-order factor models (with both the three and the four fac-
tors), although results did not convergent to admissible solution.
If this model provides better fit to the data, the domain would
consist of a single broad somatization construct that can be bro-
ken down into specific manifestations or facets. Thus, it is possible
to calculate a total score of somatic symptoms by adding up all
the items as well as to use different dimensions that might better
reflect the complexity of the somatization construct in children
and adolescents.
Second, the Cronbach’s alpha of the CSI-24 was 0.91. Studies
conducted in the US and Turkey (14, 33) have similarly shown
high internal consistency for the CSI-24, with Cronbach’s Alphas
ranging from 0.90 to 0.91. Third, similar to previous studies
(3), girls reported significantly higher number of somatic symp-
toms than boys. The reason for this gender difference is unclear
although biological factors related to puberty (e.g., menstruation)
have been considered as contributing to higher somatic symp-
toms in girls (34). The role of age in somatic symptoms is less
clear. In the study by Vila et al. (3) in the UK, the 11- to 12-year-
olds had significantly higher scores than the 13- to 14-year-olds.
It was argued that the 11- to 12-year-olds were more stressed
than the 13- to 14-year-olds as they needed to adapt to a new
school.
Fourth, in agreement with several studies (3), the Polish CSI-24
has a good convergent validity. Specifically, the CSI-24 total score
correlated significantly with the SCAS, and the SDQ, suggesting
that a high level of somatic symptoms was associated with a high
level of anxiety and emotional problems. The CSI-24 showed good
construct validity as evidenced by the significant positive correla-
tions with the anxiety symptoms as measured by the SCAS and on
the emotional subscale of the SDQ. These findings are consistent
with previous studies that showed significant correlation between
somatic and two internalizing problems [i.e., anxiety, and emo-
tional symptoms (35)]. In agreement with previous studies (3),
somatic symptoms had low correlation with behavioral problems
(which is an example of an externalizing problem), suggesting
adequate discriminant validity. These findings seem to suggest
that the CSI-24 can be used to distinguish internalizing from
externalizing problems. Internalizing problems are inner-directed
which cause distress to oneself, while as externalizing problems are
outer-directed which cause distress to others (36).
There are several limitations to the present study, which need
to be taken into consideration when interpreting our results. First,
our participants were 12- to 17-year-olds who were recruited from
school settings. The use of a community sample may have implica-
tions for the generalizability of our findings to other populations
such as those in clinical setting or younger age groups. Second,
the data were based on self-report; however children and ado-
lescents have been reported to be better informants than parents
because of the internalizing experiences of some somatic symp-
toms. Indeed studies have reported disagreement between children
and their parents when reporting somatic symptoms (37), with
mothers reporting more somatic symptoms than the children.
Third, because the CSI-24 does not provide information on pos-
sible medical explanations for symptoms, it is unclear whether or
not the symptoms reported on the CSI-24 are an expression of
organic problems. These limitations notwithstanding, our find-
ings support the usefulness of the CSI-24 as an efficient way of
screening for somatic symptoms in children and adolescents in
Poland.
Future studies should replicate the present study in other
settings (e.g., clinical setting) and age groups.
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